The Complete Bug Bite & Bullseye Mark Guide: Identification, Treatment, and Relief
By Chloe Bennett
If you present to a clinic with an expanding ring measuring over 5 centimeters, clinicians rarely wait for blood tests before taking action. Early-stage serology, such as the standard two-tier ELISA and Western blot test, exhibits low sensitivity during the first two weeks of infection because the host immune system has not yet mounted a detectable IgG or IgM antibody response. As a result, recognized guidelines from the Infectious Diseases Society of America (IDSA) direct clinicians to diagnose early Lyme disease purely on clinical grounds when an expanding annular rash occurs after visiting an endemic region.
When treating verified erythema migrans, prompt antibiotic therapy forms the foundation of clinical care:
- Doxycycline: The first-line regimen for non-pregnant adults and children, typically prescribed at 100 mg twice daily for 10 to 14 days. It covers *Borrelia burgdorferi* while clearing potential co-infections such as *Anaplasma phagocytophilum*.
- Amoxicillin: The preferred alternative for pregnant or lactating patients, dosed at 500 mg three times daily for 14 days.
- Cefuroxime Axetil: A dependable second-line cephalosporin used when penicillin and tetracycline classes are clinically contraindicated.
For secondary bacterial cellulitis stemming from surface scratching, oral beta-lactams such as cephalexin or dicloxacillin remain the gold standard, providing robust coverage against Streptococcus and methicillin-susceptible Staphylococcus aureus. If community-acquired MRSA is suspected based on regional resistance rates or purulent drainage, providers frequently pivot to trimethoprim-sulfamethoxazole or clindamycin.
Completing the full antibiotic regimen remains non-negotiable. Halting treatment early simply because the rash clears allows persistent bacterial reservoirs to survive, dramatically elevating the risk of late-stage complications such as migratory arthritis, facial nerve palsy, and carditis.
Chloe Bennett explores the intersection of pop culture, streaming entertainment, digital trends, and contemporary lifestyle. Her weekly commentary reaches thousands of culture enthusiasts.
